查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2018770

定序試劑市場：依產品類型、技術、應用和最終用戶分類－2026-2032年全球市場預測

Sequencing Reagents Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，定序試劑市場價值將達到 62 億美元，到 2026 年將成長至 68.9 億美元，到 2032 年將達到 128 億美元，年複合成長率為 10.91%。

主要市場統計數據
基準年 2025 62億美元
預計年份：2026年 68.9億美元
預測年份 2032 128億美元
複合年成長率 (%) 10.91%

對定序試劑市場進行概述，重點在於技術差異化、採購現狀和平台主導的供應商趨勢。

定序試劑產業處於分子生物學創新與下游應用（包括診斷、藥物研發和環境基因體學）的關鍵交會點。先導化合物長度、通量和化學技術的進步，使得試劑需求從通用組分轉向高度專業化、平台最佳化的配方。這種演變造就了充滿活力的供應商環境，其中試劑品質、批間一致性以及與酵素和標記化學相關的智慧財產權決定了各個實驗室對試劑的採用和性能。

技術進步、平台生態系統整合以及確保供應鏈韌性的需求正在重新定義試劑供應商的角色和產品策略。

定序試劑市場正受到多種變革性因素的重塑，這些因素提高了對供應商應對力和產品特異性的整體標準。新一代和第三代化學技術的進步推動了對能夠支援更精確合成、更寬動態範圍以及與日益樣品製備流程相容的試劑的需求。同時，RNA定序和總體基因體學的不斷擴展應用也推動了對低起始量樣本、分解核酸和複雜環境基質最佳化的試劑的需求。

評估近期美國關稅措施對試劑採購、供應鏈設計和供應商本地化策略的累積影響。

美國推出的新關稅措施影響了進口商品，為定序試劑的生產商、經銷商和最終用戶帶來了複雜的商業環境。關稅調整正在改變依賴進口原料、專用酵素或成品試劑盒的試劑生產商的成本結構，這可能會影響本已預算緊張的實驗室的採購決策。在許多情況下，直接影響是需要重新評估籌資策略，包括尋找替代供應商、調整採購時間或透過重組定價模式來承擔額外成本。

基於細分的關鍵洞察揭示了產品類型、應用需求、技術選擇、最終用戶期望和平台生態系統如何決定試劑策略。

詳細的細分分析揭示了不同產品類型、應用、技術、終端用戶和平台的需求促進因素和要求各不相同。在產品類型內部，適配器和標籤、緩衝液和溶液、標記試劑、核苷酸、聚合酵素和酵素均展現出獨特的品質規格和驗證要求。特別是聚合酵素和酶，包括DNA聚合酵素、連接酶和逆轉錄酶，每種酶都有其自身的穩定性特徵和儲存條件，這會影響物流和使用者操作規程。依賴酵素的工作流程通常需要維持低溫運輸並提供清晰的操作說明以確保實驗成功，這些差異也體現在庫存計劃和客戶支援模式中。

美洲、歐洲、中東、非洲和亞太地區的區域趨勢和採購實踐會影響供應商的定位和營運重點。

區域趨勢影響著美洲、歐洲、中東和非洲以及亞太地區的採購行為、監管預期和供應鏈結構。美洲地區擁有眾多研究機構、生物技術中心和臨床檢查室，支撐著一個高度發展的試劑市場，該市場強調快速交付、技術支援以及與高通量自動化系統的整合。臨床環境中的法律規範和認證流程進一步促使供應商提供詳細的文件、品管證據和檢驗的工作流程，以促進試劑的推廣應用。

領先的試劑供應商如何利用創新、平台合作和價值鏈韌性來加強其市場地位和對客戶的價值提案？

領先的試劑供應商正透過結合技術創新、與平台供應商建立策略夥伴關係以及提供超越產品交付的增強服務來脫穎而出。對專有酶工程、穩定化化學和標記技術的投資，使供應商能夠彌補性能差距，並支持低起始量RNA定序和複雜元基因組組文庫等新興應用。同時，與儀器製造商的合作以及參與驗證項目，有助於供應商獲得優先供應商地位並簡化客戶註冊流程。

為試劑生產商和採購經理提供實用建議，以增強韌性、加快驗證速度並透過技術服務實現差異化。

為了因應不斷變化的技術需求和地緣政治壓力，產業領導者應優先採取一系列切實可行且影響深遠的措施，以平衡業務永續營運和科研績效。首先，應建立多源採購框架，對關鍵酵素和緩衝液的替代生產商進行認證，並透過標準化檢驗協議證明其等效性。這將降低單一供應商供應中斷的風險，並增強合約談判中的議價能力。

透過結合對關鍵相關人員的訪談、技術文獻的整合以及供應鏈映射，調查方法得出了對試劑市場檢驗且可操作的見解。

本分析的調查方法結合了與關鍵相關人員的對話、技術文獻整合以及供應鏈分析，從而確保了分析結果的可靠性和說服力。主要研究工作包括對實驗室經理、採購經理、平台專家和試劑研發科學家進行結構化訪談，以了解試劑性能、驗證障礙和採購限制等方面的實際優先事項。除上述對話外，還諮詢了資訊學和品質保證專家，以了解文件和法規要求。

整合策略挑戰，展示試劑品質、平台檢驗和供應鏈敏捷性如何共同決定營運韌性和部署軌跡。

綜上所述，這些證據表明試劑生態系統正變得日益專業化、服務化，並且對技術和政策主導的變革更為敏感。能夠提供高品質、平台檢驗的試劑，並擁有強大的技術支援和穩健的供應鏈的供應商，將更有能力滿足科學研究、臨床和工業終端用戶的多樣化需求。平台特定的生態系統和應用主導的需求正迫使試劑供應商採取差異化的產品策略，並投資於認證和文件能力建設，以應對監管和可重複性方面的挑戰。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：定序試劑市場：依產品類型分類

  • 適配器和標籤
  • 緩衝液和溶液
  • 標記試劑
  • 核苷酸
  • 聚合酵素和酶
    • DNA聚合酵素
    • 紗布
    • 逆轉錄酶

第9章：定序試劑市場：依技術分類

  • 次世代定序
  • 桑格定序
  • 第三代定序

第10章：定序試劑市場：依應用領域分類

  • 元基因組體定序
  • RNA定序
  • 標靶定序
  • 全基因測序

第11章定序試劑市場：依最終用戶分類

  • 學術研究
  • 合約研究機構
  • 醫療和診斷檢測機構
  • 製藥和生物技術公司

第12章定序試劑市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章定序試劑市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章定序試劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國定序試劑市場

第16章：中國定序試劑市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Merck KGaA
  • MGI Tech Co. Ltd.
  • New England Biolabs, Inc.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-A26E0E57453C

The Sequencing Reagents Market was valued at USD 6.20 billion in 2025 and is projected to grow to USD 6.89 billion in 2026, with a CAGR of 10.91%, reaching USD 12.80 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.20 billion
Estimated Year [2026] USD 6.89 billion
Forecast Year [2032] USD 12.80 billion
CAGR (%) 10.91%

A concise orientation to the sequencing reagents landscape highlighting technological differentiation, procurement realities, and platform-driven supplier dynamics

The sequencing reagents sector occupies a critical junction between molecular biology innovation and downstream applications that power diagnostics, therapeutics discovery, and environmental genomics. Technological advances in read length, throughput, and chemistry have shifted reagent requirements from general-purpose components to highly specialized, platform-optimized formulations. This evolution has produced a dynamic supplier landscape where reagent quality, lot-to-lot consistency, and intellectual property around enzymes and labeling chemistries determine adoption and performance across laboratories.

Stakeholders across academia, clinical laboratories, contract research organizations, and industry rely on a predictable supply of high-purity reagents to support experiments that demand reproducibility and regulatory compliance. At the same time, the proliferation of sequencing platforms has created parallel reagent ecosystems, each with distinct validation needs and support services. As a result, buyers now evaluate vendors not only on price and availability but also on technical support, validation data, and integration with informatics workflows.

Taken together, these dynamics underscore the need for a nuanced understanding of product categories, application-specific demands, and platform dependencies. For decision-makers, the immediate imperative is to align procurement and product development strategies with the operational realities of modern sequencing workflows while anticipating both technological and policy-driven disruptions.

How technological advances, platform ecosystem consolidation, and supply chain resilience imperatives are redefining reagent supplier roles and product strategies

The sequencing reagents landscape is being reshaped by several transformative forces that collectively raise the bar for supplier responsiveness and product specificity. Advances in next-generation and third-generation chemistries are demanding reagents that can support higher-fidelity synthesis, broader dynamic range, and compatibility with increasingly automated library-preparation workflows. Concurrently, the expansion of RNA sequencing and metagenomics applications has increased demand for reagents optimized for low-input samples, degraded nucleic acids, and complex environmental matrices.

Parallel to these technical shifts, platform vendors are deepening their ecosystem control by offering vertically integrated reagent kits and certification programs that simplify validation for end users while creating barriers for third-party suppliers. This trend has implications for new entrants and established reagent companies alike, who must decide between tight platform partnerships or broader cross-platform compatibility strategies. Supply chain resilience has become another defining variable; the pandemic-era disruptions exposed vulnerabilities in single-source dependencies for critical enzymes and high-purity buffers, prompting a wave of dual-sourcing and regional inventory strategies.

Finally, regulatory scrutiny and laboratory accreditation requirements are converging with commercial pressures to drive higher documentation standards around reagent traceability and quality systems. Collectively, these shifts are transforming reagent suppliers into strategic partners that offer technical service, validated workflows, and logistical reliability in addition to consumable products.

Assessing the cumulative effects of recent United States tariff actions on reagent sourcing, supply chain design, and supplier localization strategies

The introduction of new tariff measures affecting imports into the United States has created a complex operating environment for manufacturers, distributors, and end users of sequencing reagents. Tariff adjustments alter the cost structure for reagent producers that rely on imported raw materials, specialized enzymes, or finished kits, and they can influence procurement decisions across laboratories that face tighter operational budgets. In many cases, the immediate effect is a re-evaluation of sourcing strategies to identify alternative suppliers, shift purchasing timing, or absorb incremental costs through restructured price models.

Beyond direct cost pressures, tariffs can drive longer-term structural responses. Suppliers may accelerate efforts to localize production of critical components, pursue toll manufacturing arrangements within tariff-friendly jurisdictions, or redesign product packaging and components to alter customs classifications. These adaptations are often accompanied by increased diligence around supply chain documentation, tariff code optimization, and engagement with customs authorities to pursue exclusions or appeals where applicable.

Laboratories and procurement organizations respond by expanding qualification protocols to include supplier risk metrics and total landed cost analyses that factor in tariff exposure. Some institutions may prioritize reagents with simplified logistics or enhanced shelf life to buffer short-term disruptions. In the aggregate, tariff-driven dynamics increase the value of supplier transparency, contractual flexibility, and the capacity to demonstrate traceability and compliance across cross-border shipments.

Key segmentation-driven insights revealing how product categories, application demands, technology choices, end-user expectations, and platform ecosystems dictate reagent strategy

A granular view of segmentation reveals differentiated demand drivers and requirements across product types, applications, technologies, end users, and platforms. Within product type, adapters and tags, buffers and solutions, labeling reagents, nucleotides, and polymerases and enzymes each exhibit distinct quality specifications and validation needs; polymerases and enzymes in particular encompass DNA polymerases, ligases, and reverse transcriptases, each carrying unique stability profiles and storage conditions that affect logistics and user protocols. These distinctions inform inventory planning and customer support models because enzyme-dependent workflows often require cold-chain integrity and clear handling instructions to ensure experimental success.

Application domains further shape reagent selection criteria. Metagenomics sequencing places premium value on contamination controls and robust extraction chemistries capable of addressing diverse sample matrices, while RNA sequencing emphasizes reagents that preserve labile transcripts and minimize degradation. Targeted sequencing workflows prioritize high-specificity labeling and adapter systems that enable multiplexing, and whole genome sequencing demands reagents that support uniform coverage and minimal bias across extensive libraries. These application-level requirements drive demand for technical documentation, validated protocols, and certification for clinical or regulatory use where applicable.

Technology segmentation underscores compatibility considerations. Next-generation sequencing platforms often favor reagent kits optimized for short-read chemistries and high-throughput automation, Sanger sequencing retains a niche for targeted validation with long-established reagent conventions, and third-generation sequencing requires chemistries tailored for long reads and single-molecule fidelity. End-user segmentation-spanning academic research, contract research organizations, healthcare and diagnostic laboratories, and pharmaceutical and biotechnology companies-creates varying expectations for scale, documentation, and turnaround times; academic labs may prioritize cost and flexibility, whereas diagnostics labs demand reproducible lot-to-lot performance and regulatory-grade traceability.

Platform-specific ecosystems introduce another layer of complexity. Major instrument families include Illumina, Oxford Nanopore, PacBio, and Thermo Fisher, each supported by platform-tailored consumables and accessory instruments. Within those families, sub-platforms such as Illumina's MiSeq, NextSeq, and NovaSeq; Oxford Nanopore's MinION and PromethION; PacBio's RS II and Sequel; and Thermo Fisher's Ion Torrent and QuantStudio require specific reagent formats, validation steps, and user training. Suppliers that align product development and validation with platform APIs and service networks can shorten customer qualification cycles and increase adoption in platform-locked environments.

Regional dynamics and procurement behaviors across the Americas, Europe Middle East and Africa, and Asia-Pacific that drive supplier positioning and operational priorities

Regional dynamics shape procurement behaviors, regulatory expectations, and supply chain architectures across the Americas, Europe Middle East and Africa, and Asia-Pacific. In the Americas, a concentration of research institutions, biotech hubs, and clinical laboratories supports a sophisticated reagent market that values rapid delivery, technical support, and integration with high-throughput automation. Regulatory frameworks and accreditation processes in clinical settings further incentivize suppliers to provide detailed documentation, quality management evidence, and validated workflows to facilitate adoption.

Across Europe, the Middle East and Africa, heterogeneity in healthcare infrastructure and research capacity results in divergent buyer priorities. Western European markets typically emphasize regulatory conformity, supplier certifications, and sustainability considerations, whereas emerging markets focus on affordability and logistical accessibility. The broader EMEA region also exhibits complex cross-border supply considerations and customs regimes that affect lead times and inventory planning.

The Asia-Pacific region combines rapidly expanding sequencing adoption with a strong manufacturing base for reagents and components. Laboratories in APAC often seek local-formulation expertise, rapid technical response, and competitive pricing, while regional manufacturers and contract producers offer opportunities for nearshoring and cost-effective sourcing. Across all regions, the shared priorities are predictable supply, compliance with local regulatory and import requirements, and the ability of suppliers to provide technical training and application support tailored to regional use cases.

How top reagent suppliers are leveraging innovation, platform partnerships, and supply chain resilience to strengthen market position and customer value propositions

Leading reagent suppliers are differentiating through a combination of technical innovation, strategic partnerships with platform vendors, and enhanced service offerings that go beyond product delivery. Investments in proprietary enzyme engineering, stabilization chemistries, and labeling technologies enable suppliers to address performance gaps and support emerging applications such as low-input RNA sequencing and complex metagenomic libraries. At the same time, collaboration with instrument manufacturers and participation in validation programs creates pathways for preferred supplier status and streamlined customer onboarding.

Beyond product R&D, companies are strengthening supply chain resilience by diversifying manufacturing footprints, qualifying alternate raw material sources, and implementing stricter quality control regimes. These operational measures reduce the risk of disruption and support contractual commitments for availability. Customer-facing capabilities are also expanding, with many suppliers offering technical training, workflow optimization services, and customized reagent kits that bundle reagents with validated protocols and data analysis guidance.

Competitive dynamics favor organizations that can combine robust scientific IP with transparent regulatory documentation and responsive logistical models. Strategic M&A and alliances continue to be tools for accessing complementary technologies, broadening product portfolios, and accelerating entrance into new application areas or geographic regions. For buyers, these trends mean an increased emphasis on evaluating supplier capability across R&D, manufacturing, and post-sale support rather than focusing solely on unit pricing.

Actionable recommendations enabling reagent manufacturers and procurement leaders to enhance resilience, accelerate validation, and differentiate through technical service offerings

To navigate a landscape of evolving technological requirements and geopolitical pressures, industry leaders should prioritize a set of pragmatic, high-impact actions that align operational resilience with scientific performance. First, establish multi-source procurement frameworks that qualify alternative manufacturers for critical enzymes and buffers while documenting equivalency through standardized validation protocols. This reduces exposure to single-source disruptions and provides leverage during contract negotiations.

Second, invest in close technical partnerships with platform vendors and clinical laboratories to co-develop validated reagent kits and certification pathways that shorten adoption cycles. Such collaborations can include cross-validation studies, co-branded training materials, and joint technical support to ensure reproducible outcomes across instrument generations. Third, optimize supply chain design by localizing inventory for time-sensitive reagents, implementing cold-chain redundancies, and employing tariff-savvy logistics strategies to mitigate import-related cost volatility.

Fourth, strengthen regulatory and quality documentation by adopting internationally recognized quality management standards, enhancing traceability of raw materials, and maintaining thorough stability and lot-release data. Fifth, prioritize customer-centric services such as turnkey library preparation kits, automation-friendly formats, and on-demand technical assistance to differentiate offerings beyond price. Collectively, these actions will help organizations maintain operational continuity, preserve scientific integrity in laboratory workflows, and sustain competitive advantage amid shifting market conditions.

Methodological framework combining primary stakeholder interviews, technical literature synthesis, and supply chain mapping to produce validated and actionable reagent market insights

The research methodology underpinning this analysis combined primary stakeholder engagements, technical literature synthesis, and supply chain mapping to ensure robust and defensible insights. Primary research included structured interviews with laboratory directors, procurement leads, platform specialists, and reagent development scientists to capture real-world priorities around reagent performance, validation hurdles, and sourcing constraints. These conversations were supplemented by expert consultations with informatics and quality assurance professionals to understand documentation and regulatory expectations.

Secondary research drew on peer-reviewed publications, validation studies, and manufacturer documentation to corroborate technical trends in sequencing chemistry and platform requirements. Supply chain mapping identified critical nodes for raw material procurement, contract manufacturing relationships, and cold-chain dependencies, which informed risk assessments and mitigation strategies. Data triangulation and cross-validation were employed throughout to reconcile perspectives from different stakeholder groups and to surface consistent patterns in supplier behavior and buyer expectations.

Limitations of the methodology include variability in lab-level practices across institutions and the evolving nature of platform-specific reagent ecosystems, which means some operational nuances may shift as new chemistries and instrument versions are introduced. Ethical considerations and confidentiality safeguards were observed during primary engagements, and methodological transparency was maintained to allow replication of key analytical steps where feasible.

Synthesis of strategic imperatives showing how reagent quality, platform validation, and supply chain agility jointly determine operational resilience and adoption trajectories

The collective evidence points to a reagent ecosystem that is increasingly specialized, service-oriented, and sensitive to both technological and policy-driven disruptions. Suppliers that can deliver high-quality, platform-validated reagents while offering robust technical support and resilient supply chains will be better positioned to meet the diverse needs of research, clinical, and industrial end users. Platform-specific ecosystems and application-driven requirements are compelling reagent providers to adopt differentiated product strategies and to invest in certification and documentation capabilities that address regulatory and reproducibility concerns.

At the same time, geopolitical developments and tariff realignments have elevated the importance of supply chain agility and tariff-aware logistics, prompting both suppliers and laboratories to reassess sourcing strategies and inventory management. The net effect is a market environment where scientific excellence must be matched by operational reliability and commercial flexibility. For stakeholders across the value chain, the priority is to convert technical know-how into reproducible, validated solutions that can be reliably deployed at scale, regardless of regional or policy-related disruptions.

Looking forward, the interplay between platform innovation, application diversification, and supply chain resilience will continue to shape competitive dynamics and adoption patterns within the sequencing reagents domain.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Sequencing Reagents Market, by Product Type

  • 8.1. Adapters And Tags
  • 8.2. Buffers And Solutions
  • 8.3. Labeling Reagents
  • 8.4. Nucleotides
  • 8.5. Polymerases And Enzymes
    • 8.5.1. Dna Polymerases
    • 8.5.2. Ligases
    • 8.5.3. Reverse Transcriptases

9. Sequencing Reagents Market, by Technology

  • 9.1. Next-Generation Sequencing
  • 9.2. Sanger Sequencing
  • 9.3. Third-Generation Sequencing

10. Sequencing Reagents Market, by Application

  • 10.1. Metagenomics Sequencing
  • 10.2. RNA Sequencing
  • 10.3. Targeted Sequencing
  • 10.4. Whole Genome Sequencing

11. Sequencing Reagents Market, by End User

  • 11.1. Academic Research
  • 11.2. Contract Research Organizations
  • 11.3. Healthcare And Diagnostic Laboratories
  • 11.4. Pharmaceutical And Biotechnology Companies

12. Sequencing Reagents Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Sequencing Reagents Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Sequencing Reagents Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Sequencing Reagents Market

16. China Sequencing Reagents Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agilent Technologies, Inc.
  • 17.6. BGI Genomics Co., Ltd.
  • 17.7. Danaher Corporation
  • 17.8. F. Hoffmann-La Roche Ltd.
  • 17.9. Illumina, Inc.
  • 17.10. Merck KGaA
  • 17.11. MGI Tech Co. Ltd.
  • 17.12. New England Biolabs, Inc.
  • 17.13. Oxford Nanopore Technologies plc
  • 17.14. Pacific Biosciences of California, Inc.
  • 17.15. Promega Corporation
  • 17.16. QIAGEN N.V.
  • 17.17. Takara Bio Inc.
  • 17.18. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SEQUENCING REAGENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SEQUENCING REAGENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ADAPTERS AND TAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ADAPTERS AND TAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ADAPTERS AND TAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LABELING REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LABELING REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LABELING REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NUCLEOTIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NUCLEOTIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NUCLEOTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY DNA POLYMERASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY DNA POLYMERASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY DNA POLYMERASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LIGASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LIGASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LIGASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REVERSE TRANSCRIPTASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REVERSE TRANSCRIPTASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REVERSE TRANSCRIPTASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY METAGENOMICS SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY METAGENOMICS SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY METAGENOMICS SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY HEALTHCARE AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY HEALTHCARE AND DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY HEALTHCARE AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. GCC SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GCC SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. GCC SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 123. GCC SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. GCC SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. GCC SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. G7 SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. G7 SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. G7 SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 141. G7 SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. G7 SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. G7 SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. NATO SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. NATO SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. NATO SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 147. NATO SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. NATO SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. NATO SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. CHINA SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. CHINA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. CHINA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)